Cancerguard
Multi-cancer early detection laboratory-developed test for adults 50–84; breast/prostate screening and precancer detection are outside the documented current use.
- Developer
- Exact Sciences
- Intended use
- Multi Cancer Screening
- Cancer scope
- Anal cancer, Bladder cancer, Cervical cancer, Colorectal cancer, Esophageal cancer, Head and neck cancer, Kidney cancer, Liver cancer, Lung cancer, Non-Hodgkin lymphoma, Ovarian cancer, Pancreatic cancer, Small intestine cancer, Stomach cancer, Testicular cancer, Thyroid cancer, Uterine cancer, Vulvar cancer
- Specimen
- Plasma, Whole blood
- Molecular modality
- DNA methylation, Protein
- Current version
- Current Cancerguard commercial configuration documented by Exact Sciences
- Evidence context
- 2 structured studies · 4 indexed performance results · 3 sources
Why can reported performance numbers differ? MDI keeps each result attached to its study, population, stage or stratum, test version and source rather than treating performance as a fixed property of the test.